Search research articles
Contact Us
Filters
Showing results (431-440 of 621) with videos related to
Page
of 63
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2014
FcγRIIa and FcγRIIIa polymorphisms and cetuximab benefit in the microscopic disease
Francesco Sclafani, David Gonzalez de Castro, David Cunningham, et al.
JAMA Oncology
|
February 28, 2017
Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial
Elizabeth C Smyth, Andrew Wotherspoon, Clare Peckitt, et al.
Annals of Hematology
|
November 29, 2019
R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial
Andrea Kühnl, Clare Peckitt, Bijal Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 12, 2012
Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III)
Hans-Joachim Schmoll, David Cunningham, Alberto Sobrero, et al.
Frontiers in Oncology
|
December 14, 2023
MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patients
Hazel Lote, Florentia Mousoullou, George Vlachogiannis, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 21, 2023
Outcomes of Patients Treated With RCHOP With a PET-Adapted Approach for Consolidative Radiotherapy: A Retrospective Single-Center Study at the Royal Marsden Hospital
Su Li, Bhupinder Sharma, Siraj Yusuf, et al.
BMC Cancer
|
April 14, 2017
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials
Mairéad Geraldine McNamara, John Bridgewater, Andre Lopes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 22, 2014
Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumours
Tim Meyer, Wendi Qian, Martyn E Caplin, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
June 17, 2025
Characteristics of Ipsilateral Corticomotor Pathways in People with cervical spinal cord Injury
Jia Liu, Madeline Cantu, Kyle O'Laughlin, et al.
Lancet (London, England)
|
April 26, 2013
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles
David Cunningham, Eliza A Hawkes, Andrew Jack, et al.
Page
of 63
Search research articles
Search
Showing results (431-440 of 621) with videos related to
Sort By:
Page
of 63
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2014
FcγRIIa and FcγRIIIa polymorphisms and cetuximab benefit in the microscopic disease
Francesco Sclafani, David Gonzalez de Castro, David Cunningham, et al.
JAMA Oncology
|
February 28, 2017
Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial
Elizabeth C Smyth, Andrew Wotherspoon, Clare Peckitt, et al.
Annals of Hematology
|
November 29, 2019
R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial
Andrea Kühnl, Clare Peckitt, Bijal Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 12, 2012
Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III)
Hans-Joachim Schmoll, David Cunningham, Alberto Sobrero, et al.
Frontiers in Oncology
|
December 14, 2023
MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patients
Hazel Lote, Florentia Mousoullou, George Vlachogiannis, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 21, 2023
Outcomes of Patients Treated With RCHOP With a PET-Adapted Approach for Consolidative Radiotherapy: A Retrospective Single-Center Study at the Royal Marsden Hospital
Su Li, Bhupinder Sharma, Siraj Yusuf, et al.
BMC Cancer
|
April 14, 2017
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials
Mairéad Geraldine McNamara, John Bridgewater, Andre Lopes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 22, 2014
Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumours
Tim Meyer, Wendi Qian, Martyn E Caplin, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
June 17, 2025
Characteristics of Ipsilateral Corticomotor Pathways in People with cervical spinal cord Injury
Jia Liu, Madeline Cantu, Kyle O'Laughlin, et al.
Lancet (London, England)
|
April 26, 2013
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles
David Cunningham, Eliza A Hawkes, Andrew Jack, et al.
Page
of 63